FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029968169> ?p ?o ?g. }

• W2029968169 endingPage "31" @default.
• W2029968169 startingPage "26" @default.
• W2029968169 abstract "In view of the large body of evidence for the role of histamine and cysteinyl leukotrienes (CysLT 1 ) in the pathogenesis of allergic rhinitis (AR) and asthma, there has been a surge in the development of histamine H 1 and CysLT 1 receptor antagonists (Hi antihistamines and leukotriene antagonists, respectively) for the treatment of these conditions. Current treatment guidelines recommend the use of oral H 1 antihistamines as first-choice treatment for intermittent or persistent AR and the leukotriene antagonists, either as alternative or add-on therapy to inhaled corticosteroids, for mild-to-moderate persistent asthma. However, recent studies, using a variety of traditional and novel outcome measures, have suggested that the H 1 antihistamines and leukotriene receptor antagonists (LTRAs) may be effective in both asthma and AR. However, these studies have provided conflicting evidence as to whether H 1 antihistamines and the leukotriene antagonists have the potential for additivity of response, when used as combination therapy in AR. There are also preliminary data showing that H 1 antihistamines, like LTRAs, may further reduce inflammation, when used as add-on therapy to inhaled corticosteroids in patients with mild-to-moderate persistent asthma. The clinical relevance of these findings, however, is presently not clear and also, the observed effects of these agents are likely to be dependent on the type of outcome measures used in these studies. Further studies are therefore clearly required to evaluate the effects of combined histamine H 1 and CysLT 1 receptor antagonists in patients with more severe disease over the longer term, particularly to evaluate asthma exacerbations and airway remodelling. Furthermore, it will be important to assess the potential for treating the unified airway in patients with concomitant asthma and AR in terms of comparing combined mediator antagonism with topical corticosteroid therapy." @default.
• W2029968169 created "2016-06-24" @default.
• W2029968169 creator A5054519215 @default.
• W2029968169 date "2005-07-01" @default.
• W2029968169 modified "2023-09-24" @default.
• W2029968169 title "Pharmacological interventions and outcome measurements in the unified airway" @default.
• W2029968169 cites W1966146541 @default.
• W2029968169 cites W1984791769 @default.
• W2029968169 cites W1988345297 @default.
• W2029968169 cites W1990064226 @default.
• W2029968169 cites W1998504825 @default.
• W2029968169 cites W2016060261 @default.
• W2029968169 cites W2021443970 @default.
• W2029968169 cites W2024931777 @default.
• W2029968169 cites W2032470063 @default.
• W2029968169 cites W2042256859 @default.
• W2029968169 cites W2047537824 @default.
• W2029968169 cites W2057992720 @default.
• W2029968169 cites W2087519128 @default.
• W2029968169 cites W2090477973 @default.
• W2029968169 cites W2090625779 @default.
• W2029968169 cites W2096210343 @default.
• W2029968169 cites W2099757442 @default.
• W2029968169 cites W2100110654 @default.
• W2029968169 cites W2109306397 @default.
• W2029968169 cites W2120604664 @default.
• W2029968169 cites W2121872020 @default.
• W2029968169 cites W2126356383 @default.
• W2029968169 cites W2129964076 @default.
• W2029968169 cites W2133415387 @default.
• W2029968169 cites W2134303643 @default.
• W2029968169 cites W2139606678 @default.
• W2029968169 cites W2160282112 @default.
• W2029968169 cites W4254386551 @default.
• W2029968169 cites W71227319 @default.
• W2029968169 doi "https://doi.org/10.1111/j.1365-2222.2005.0079.x" @default.
• W2029968169 hasPublicationYear "2005" @default.
• W2029968169 type Work @default.
• W2029968169 sameAs 2029968169 @default.
• W2029968169 citedByCount "1" @default.
• W2029968169 crossrefType "journal-article" @default.
• W2029968169 hasAuthorship W2029968169A5054519215 @default.
• W2029968169 hasConcept C1122143 @default.
• W2029968169 hasConcept C203014093 @default.
• W2029968169 hasConcept C2776042228 @default.
• W2029968169 hasConcept C2776452501 @default.
• W2029968169 hasConcept C71924100 @default.
• W2029968169 hasConcept C98274493 @default.
• W2029968169 hasConceptScore W2029968169C1122143 @default.
• W2029968169 hasConceptScore W2029968169C203014093 @default.
• W2029968169 hasConceptScore W2029968169C2776042228 @default.
• W2029968169 hasConceptScore W2029968169C2776452501 @default.
• W2029968169 hasConceptScore W2029968169C71924100 @default.
• W2029968169 hasConceptScore W2029968169C98274493 @default.
• W2029968169 hasIssue "1" @default.
• W2029968169 hasLocation W20299681691 @default.
• W2029968169 hasOpenAccess W2029968169 @default.
• W2029968169 hasPrimaryLocation W20299681691 @default.
• W2029968169 hasRelatedWork W2046431669 @default.
• W2029968169 hasRelatedWork W2049092366 @default.
• W2029968169 hasRelatedWork W2061386133 @default.
• W2029968169 hasRelatedWork W2072655284 @default.
• W2029968169 hasRelatedWork W2073042452 @default.
• W2029968169 hasRelatedWork W2396020519 @default.
• W2029968169 hasRelatedWork W2970795870 @default.
• W2029968169 hasRelatedWork W2992709694 @default.
• W2029968169 hasRelatedWork W3031499055 @default.
• W2029968169 hasRelatedWork W4245540480 @default.
• W2029968169 hasVolume "5" @default.
• W2029968169 isParatext "false" @default.
• W2029968169 isRetracted "false" @default.
• W2029968169 magId "2029968169" @default.
• W2029968169 workType "article" @default.